‘Illegally marketed’: CRN calls for FDA response to study on galantamine products
The Council for Responsible Nutrition is calling on the U.S. Food and Drug Administration (FDA) to act against products formulated with the Alzheimer drug galantamine and marketed as dietary supplements .